Par Drugs and Chemicals Limited (NSE:PAR)
India · Delayed Price · Currency is INR 101.33
-1.15 (-1.12%)
Aug 21, 2026, 3:29 PM IST
Par Drugs and Chemicals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,247 | 967 | 1,045 | 2,651 | 1,723 | 1,966 | |
Market Cap Growth | 2.35% | -7.48% | -60.58% | 53.89% | -12.36% | 158.08% |
Enterprise Value | 828 | 628 | 857 | 2,352 | 1,565 | 1,826 |
Last Close Price | 101.33 | 78.58 | 84.93 | 215.45 | 140.00 | 159.75 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 8.60 | 7.38 | 7.82 | 18.28 | 15.20 | 21.34 |
PS Ratio | 1.15 | 0.93 | 1.03 | 2.77 | 1.80 | 2.62 |
PB Ratio | 1.11 | 0.86 | 1.06 | 3.10 | 2.42 | 3.28 |
P/TBV Ratio | 1.11 | 0.86 | 1.06 | 3.10 | 2.42 | 3.28 |
P/FCF Ratio | 8.62 | 6.68 | 7.00 | 18.71 | 29.99 | 44.54 |
P/OCF Ratio | 7.59 | 5.88 | 6.47 | 13.09 | 12.88 | 25.81 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.76 | 0.61 | 0.85 | 2.46 | 1.64 | 2.43 |
EV/EBITDA Ratio | 4.16 | 3.67 | 4.39 | 10.31 | 8.60 | 11.24 |
EV/EBIT Ratio | 5.12 | 4.68 | 5.40 | 12.14 | 10.45 | 14.08 |
EV/FCF Ratio | 5.72 | 4.34 | 5.74 | 16.60 | 27.25 | 41.38 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Debt / Equity Ratio | -0.37 | -0.37 | -0.28 | -0.43 | -0.31 | -0.27 |
Net Debt / EBITDA Ratio | -2.10 | -2.44 | -1.41 | -1.61 | -1.22 | -1.00 |
Net Debt / FCF Ratio | - | -2.89 | -1.85 | -2.59 | -3.87 | -3.67 |
Asset Turnover | - | 0.83 | 0.91 | 1.00 | 1.14 | 0.97 |
Inventory Turnover | - | 7.50 | 7.38 | 6.67 | 7.15 | 6.25 |
Quick Ratio | - | 3.92 | 2.67 | 4.05 | 2.80 | 2.34 |
Current Ratio | - | 4.68 | 3.31 | 4.79 | 3.53 | 2.93 |
Return on Equity (ROE) | - | 12.43% | 14.47% | 18.49% | 17.29% | 16.44% |
Return on Assets (ROA) | - | 6.75% | 8.97% | 12.72% | 11.17% | 10.46% |
Return on Invested Capital (ROIC) | 17.46% | 14.38% | 19.64% | 29.40% | 24.29% | 22.66% |
Return on Capital Employed (ROCE) | - | 11.60% | 15.40% | 21.70% | 20.00% | 20.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 11.62% | 13.56% | 12.78% | 5.47% | 6.58% | 4.69% |
FCF Yield | 11.61% | 14.97% | 14.29% | 5.34% | 3.33% | 2.25% |
Dividend Yield | - | - | - | - | - | 0.78% |
Payout Ratio | - | - | - | - | - | 16.61% |
Buyback Yield / Dilution | 0.04% | -0.03% | - | - | - | - |
Total Shareholder Return | 0.04% | -0.03% | - | - | - | 0.78% |